Overview
Deepy Sur practices practicing medicine in Toronto, Canada.
Their clinical expertise encompasses Cannabinoid Hyperemesis Syndrome (CHS), Severe Acute Respiratory Syndrome (SARS), and COVID-19.
They are actively involved in clinical research, co-authoring 18 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Deepy Sur
Is Deepy Sur a top-rated expert for Cannabinoid Hyperemesis Syndrome (CHS)?
MediFind is an objective health platform that identifies experts based on real-world data. Deepy Sur is classified as an Experienced expert for Cannabinoid Hyperemesis Syndrome (CHS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Deepy Sur participate in research or clinical trials?
Yes. Deepy Sur has published 18 articles and abstracts on conditions like Cannabinoid Hyperemesis Syndrome (CHS). You can view a list of Deepy Sur's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cannabinoid Hyperemesis Syndrome (CHS)
- COVID-19Sur isExperienced. Learn about COVID-19.
- Severe Acute Respiratory Syndrome (SARS)